Symbiosis of diagnostics and therapy

Mosaiques Diagnostics & Therapeutics AG has pursued this goal through intensive research over the last 20 years and has developed a technology to transfer this vision into practice. The technology is now available to detect diseases as early as possible and with unprecedented precision. This is what makes it possible to effectively treat diseases with drug therapies at the earliest timepoint.

Mosaique's clinical proteome analysis enables:

1) Detection of diseases before organ damage occurs,

2) Treatment of diseases in the earliest phase of their development in order to prevent organ damage and painful symptoms,

3) Individual optimisation of drug treatment medication: monitoring the drug treatment efficiency and variable adjustment of drug response, as well as drug dosage,

4) Faster, targeted drug development.